Cargando…
Monitoring Patients with Metastatic Hormone-Sensitive and Metastatic Castration-Resistant Prostate Cancer: A Multidisciplinary Consensus Document
Background: The availability of a number of agents that are efficacious in patients with metastatic prostate cancer (mPC) has led to them being used sequentially, and this has prolonged patient survival. However, in order to maximize their efficacy, clinicians need to be able to obtain a reliable pi...
Autores principales: | Lapini, Alberto, Caffo, Orazio, Pappagallo, Giovanni, Iacovelli, Roberto, D’Angelillo, Rolando Maria, Vavassori, Vittorio, Ceccarelli, Roberta, Bracarda, Sergio, Jereczek-Fossa, Barbara Alicja, Da Pozzo, Luigi, Conti, Giario Natale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966424/ https://www.ncbi.nlm.nih.gov/pubmed/31805687 http://dx.doi.org/10.3390/cancers11121908 |
Ejemplares similares
-
Metastatic castration-resistant prostate cancer in very elderly patients: challenges and solutions
por: Caffo, Orazio, et al.
Publicado: (2016) -
Feasibility of abiraterone acetate treatment in patients with metastatic castration-resistant prostate cancer and atrial fibrillation
por: Rauch, Simon, et al.
Publicado: (2016) -
The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria
por: Bottero, Marta, et al.
Publicado: (2021) -
Targeted Approaches in Metastatic Castration-Resistant Prostate Cancer: Which Data?
por: Mosillo, Claudia, et al.
Publicado: (2022) -
Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy
por: Verzoni, Elena, et al.
Publicado: (2022)